The DRC Regional Metabolomics Core at Princeton provides Penn DRC investigators with access to state-of- the-art metabolomics and flux analysis. These capabilities allow DRC investigators to measure, both broadly and quantitatively, metabolic activity in cell culture, animal model, and clinical specimens relevant to diabetes and obesity. Now entering its 5th year, the Core has seen steadily increasing usage and is on track to analyze over 5000 samples in 2016. Thus, investigator demand for its services are high. This reflects the Core's position as a leader in metabolomics and lipidomics, with a particular focus on integration of these technologies with isotope tracing to reveal dynamic metabolic activity.
In Aim 1, the Core will provide metabolomics services covering approximately 300 water-soluble metabolites and approximately 500 lipids. This will be achieved via mass spectroscopy-based analytical methods validated for their specificity and quantitative reproducibility.
Aim 2 focuses on isotope tracer studies. To this end, the Core will guide tracer study design, carry out labeling pattern measurement, and facilitate data interpretation for both cell culture and in vivo research. Methods are now in place to trace major circulating nutrients in mice, and are being actively utilized to investigate mouse models of obesity and diabetes.
Aim 3 involves expansion of the Core's capabilities. Beyond continuous improvement in breadth, depth, and quantitative reproducibility of metabolome coverage, this will include (i) new methods for in vivo tracing and (ii) establishment of a new joint Penn-Princeton Clinical Metabolomics Team to further increase clinical application of the Core's capabilities. The net effect will be to augment the scientific and clinical impact of the DRC through use of transformative metabolomics and flux analysis approaches to better understand?and thereby eventually more effectively diagnose and treat? diabetes, obesity, and related metabolic disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK019525-44
Application #
9918898
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Pei, Liming; Wallace, Douglas C (2018) Mitochondrial Etiology of Neuropsychiatric Disorders. Biol Psychiatry 83:722-730
Brown, Justin C; Rickels, Michael R; Troxel, Andrea B et al. (2018) Dose-response effects of exercise on insulin among colon cancer survivors. Endocr Relat Cancer 25:11-19
Rickels, M R; Markmann, E; Naji, A (2018) Successful pregnancies after islet transplantation for type 1 diabetes. Am J Transplant :
Friedman, Elliot S; Li, Yun; Shen, Ting-Chin David et al. (2018) FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid. Gastroenterology 155:1741-1752.e5
Rickels, Michael R; DuBose, Stephanie N; Toschi, Elena et al. (2018) Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes. Diabetes Care 41:1909-1916
Jang, Cholsoon; Hui, Sheng; Lu, Wenyun et al. (2018) The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids. Cell Metab 27:351-361.e3
Juliana, Christine A; Yang, Juxiang; Cannon, Corey E et al. (2018) A PDX1-ATF transcriptional complex governs ? cell survival during stress. Mol Metab 17:39-48
McKee, Sarah E; Zhang, Sisi; Chen, Li et al. (2018) Perinatal high fat diet and early life methyl donor supplementation alter one carbon metabolism and DNA methylation in the brain. J Neurochem 145:362-373
Wangensteen, Kirk J; Wang, Yue J; Dou, Zhixun et al. (2018) Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform. Hepatology 68:663-676
Brown, Justin C; Damjanov, Nevena; Courneya, Kerry S et al. (2018) A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors. Psychooncology 27:1221-1228

Showing the most recent 10 out of 720 publications